We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Integration of AI into business operations is becoming an imperative for many organizations. Leaders need to be intentional ...